At <a href="https://twitter.com/hashtag/AHA24?src=hashtag_click" target="_blank">#AHA24</a>, attendees explored the benefits of Hybrid AF™ Therapy and learned new data from the DEEP Trial, highlighting improved QOL for patients who underwent hybrid ablation and LAAE with an AtriClip® device.
Thank you to all the physicians who connected with us!